11,657 results match your criteria: "H.L.; The University of Texas MD Anderson Cancer Center[Affiliation]"

Article Synopsis
  • ANGPTL3/4/8 proteins regulate lipoprotein lipase (LPL) activity, with ANGPTL8 forming complexes that influence ANGPTL4's function; however, their association with cardiovascular outcomes is under-researched.
  • This study involved measuring various ANGPTL proteins and complexes in two large population studies (LURIC and getABI) focusing on cardiovascular health and outcomes over several years.
  • Findings showed that while ANGPTL3/8 inhibited LPL activity and correlated with increased LDL-C and triglycerides, they did not predict cardiovascular death; however, ANGPTL4/8 and CD-ANGPTL4 were linked to higher diabetes prevalence and increased cardiovascular mortality risk.
View Article and Find Full Text PDF
Article Synopsis
  • The management of carotid artery disease has predominantly relied on the degree of stenosis, but new research indicates that features like intraplaque hemorrhage can provide better diagnostic and treatment insights.
  • Current guidelines often overlook less than 50% stenosis cases, which can lead to misdiagnosis and inadequate treatments for potential stroke causes, leaving many patients untreated.
  • There is a push to reclassify certain strokes as symptomatic nonstenotic carotid disease when high-risk plaque features are present, and this review discusses historical practices, modern biomarkers of plaque vulnerability, imaging tools, and recent studies on this emerging classification.
View Article and Find Full Text PDF
Article Synopsis
  • RNA interference (RNAi) therapeutics, specifically patisiran and vutrisiran, were studied for their effects on transthyretin amyloid cardiomyopathy (ATTR-CA) by analyzing SPECT/CT imaging outcomes.
  • Eight patients with hereditary ATTR-CA were monitored, with one group starting RNAi treatment alongside their first imaging, and another group being on treatment prior to imaging.
  • Findings revealed a significant decrease in a volumetric heart/lung ratio in patients receiving RNAi therapies, indicating potential benefits in managing ATTR-CA symptoms.
View Article and Find Full Text PDF

Prognosis of Proximal and Distal Vertebrobasilar Artery Stent Placement.

AJNR Am J Neuroradiol

November 2024

Department of Neurology (J.-H.B., J.Y.C., D.-W.K., S.U.K., B.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Article Synopsis
  • Vertebrobasilar artery stent placement (VBS) is used to prevent posterior circulation strokes, but little is known about the differences in outcomes based on whether the stent is placed intracranially or extracranially.
  • In a study of 105 patients, those with intracranial VBS experienced significantly higher rates of in-stent restenosis (21.9% vs 4.9%) and stented-territory ischemic events (32.8% vs 7.3%) compared to those with extracranial VBS.
  • The procedure for intracranial VBS took longer and had a higher rate of residual stenosis immediately after the procedure, indicating more complications associated with intracranial st
View Article and Find Full Text PDF

Background: Chronic mental stress accelerates atherosclerosis through complicated neuroimmune pathways, needing for advanced imaging techniques to delineate underlying cellular mechanisms. While histopathology, ex vivo imaging, and snapshots of in vivo images offer promising evidence, they lack the ability to capture real-time visualization of blood cell dynamics within pulsatile arteries in longitudinal studies.

Methods: An electrically tunable lens was implemented in intravital optical microscopy, synchronizing the focal plane with heartbeats to follow artery movements.

View Article and Find Full Text PDF

ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux.

Arterioscler Thromb Vasc Biol

December 2024

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC (National Health Commission) Key Laboratory of Biotechnology of Antibiotics, National Center for New Microbial Drug Screening, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China (Yuyan Zhang, X.J., W.W., L.L., R.S., S.L., J.L., J.Z., X.H., Y.L., Yuhao Zhang, C.W., S.S., Y.X.).

Background: Atherosclerosis is the most common cause of cardiovascular diseases. Clinical studies indicate that loss-of-function ASGR1 (asialoglycoprotein receptor 1) is significantly associated with lower plasma cholesterol levels and reduces cardiovascular disease risk. However, the effect of ASGR1 on atherosclerosis remains incompletely understood; whether inhibition of ASGR1 causes liver injury remains controversial.

View Article and Find Full Text PDF
Article Synopsis
  • Dual immune checkpoint blockade (ICB) using CTLA4 and PD-(L)1 inhibitors shows improved anti-tumor effectiveness and immune toxicity compared to PD-(L)1 inhibitors alone in advanced non-small-cell lung cancer (NSCLC) patients.
  • Patients with mutations in STK11 and/or KEAP1 genes benefit more from the combination treatment compared to those receiving only PD-(L)1 inhibitors, as shown in the POSEIDON trial.
  • The loss of KEAP1 serves as a strong predictor for the success of dual ICB, as it leads to a more favorable outcome by changing the tumor's immune environment to better engage CD4 and CD8 T cells for anti-tumor activity. *
View Article and Find Full Text PDF

The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.

Nature

November 2024

Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Article Synopsis
  • Advanced urothelial cancer displays significant genetic diversity and involves complex interactions between internal and external mutagens, which contributes to its deadly nature.
  • The study revealed that APOBEC3-induced mutations occur early during tumor development, while chemotherapy leads to a surge of later mutations, with both processes affecting the structure of extrachromosomal DNA.
  • Findings emphasized the role of circular ecDNA in the development of treatment resistance, specifically through CCND1 amplifications, highlighting key mechanisms that can inform future cancer therapies.
View Article and Find Full Text PDF

Assessment of Edge Modification of Nanographene.

Chemphyschem

December 2024

Department of Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8526, Japan.

Article Synopsis
  • Carboxy groups on nanographene (NG) edges allow for functionalization, which is important for creating NG-organic hybrid materials and understanding their electronic properties.
  • The study calculated the structures of model NGs with 174 carbon atoms and different functional groups, aiming for accuracy by using experimental data as a basis.
  • Results showed that while changing carboxyl groups can affect orbital energies, the HOMO-LUMO gap remains mostly unchanged, with π-extension having the most significant impact; however, Pd2+ coordination did lead to a reduction in the H-L gap due to its effect on electron transitions.
View Article and Find Full Text PDF

Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.

N Engl J Med

October 2024

From Massachusetts General Hospital and Harvard Medical School (F.E., P.L.M.) and Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School (C.N.D., D.A.W.), Boston, Bluebird Bio, Somerville (G.F.D., L.D., A.C.D., H.L.T.), and McNeil Pediatrics Consultancy, Sudbury (E.M.) - all in Massachusetts; the Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota (T.C.L., A.O.G., P.J.O.), and Midwest Radiology (D.J.L.) - both in Minneapolis; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (S.D.O., R.S., S.A.H.); University College London Great Ormond Street Hospital Institute of Child Health and Great Ormond Street Hospital NHS Trust, London (A.J.T., P.G.); INSERM, Université Paris-Saclay, Hôpital Kremlin-Bicêtre (P.A.), the Reference Center for Leukodystrophies, Hôpital Kremlin-Bicêtre, Assistance Publique-Hôpitaux de Paris, Université Paris-Saclay (C.S.), and Robert-Debre Hospital, GHU Nord-Université de Paris (J.-H.D.) - all in Paris; the Departments of Pediatric Oncology/Hematology/Hemostaseology (J.-S.K.) and Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases (U.P.), University Hospital Leipzig, Leipzig, Germany; Instituto Neurogenia and Hospital Universitario Austral - both in Buenos Aires (H.A.); Women's and Children's Health Network and the University of Adelaide - both in Adelaide, SA, Australia (N.S.); ITACI/Instituto da Criança-Hospital das Clínicas da Universidade de São Paulo, Sao Paulo (J.F.F.); and Shape Therapeutics, Seattle (A.C.D.).

Background: Cerebral adrenoleukodystrophy is a severe form of X-linked adrenoleukodystrophy characterized by white-matter disease, loss of neurologic function, and early death. Elivaldogene autotemcel (eli-cel) gene therapy, which consists of autologous CD34+ cells transduced with Lenti-D lentiviral vector containing complementary DNA, is being tested in persons with cerebral adrenoleukodystrophy.

Methods: In a phase 2-3 study, we evaluated the efficacy and safety of eli-cel therapy in boys with early-stage cerebral adrenoleukodystrophy and evidence of active inflammation on magnetic resonance imaging (MRI).

View Article and Find Full Text PDF

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.

N Engl J Med

October 2024

From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School (C.N.D., D.A.W.), the Department of Pathology, Boston Children's Hospital (J.R.B., M.H.H.), and Massachusetts General Hospital and Harvard Medical School (F.S.E.) - all in Boston; the Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center (B.G., A.B.), and the Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota (A.O.G., P.J.O.) - both in Minneapolis; Bluebird Bio, Somerville, MA (M.B., S.S., R.A.C., V.K.P., G.F.D., F.J.P., M.A.K., M.F., A.L., N.F., G.P., A.C.D., H.L.T.); the Department of Pediatric Oncology, Hematology and Hemostaseology, Leipzig University Hospital, Leipzig, Germany (J.-S.K.); and the Division of Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC (V.K.P.).

Article Synopsis
  • Gene therapy using elivaldogene autotemcel (eli-cel) has shown effectiveness in treating cerebral adrenoleukodystrophy but raises concerns about cancer risks.
  • Research analyzed blood and bone marrow samples from patients who received eli-cel to evaluate integration sites and other genetic factors.
  • Out of 67 patients treated, 7 developed hematologic cancers, with multiple instances linked to lentiviral vector insertions, though some patients successfully underwent stem cell transplantation and remained symptom-free.
View Article and Find Full Text PDF

In the current study, CO capturing ability of encapsulated ionic liquids (ENILs) , tetramethylammonium chloride (TMACl), 1,3-dimethylimidazolium chloride (MIMCl), and methylpyridinium hexafluorophosphate (MPHP) encapsulated in self assembled belt[14]pyridine (BP) has been studied. The results show that strong van der Waals forces are involved in capturing of CO by these encapsulated ionic liquids. Strong attractive forces arise from synergistic effect of ionic liquid (encapsulated) and atoms of belt.

View Article and Find Full Text PDF

IOP Reduction in Nonhuman Primates by Microneedle Injection of Drug-Free Hydrogel to Expand the Suprachoroidal Space.

Transl Vis Sci Technol

October 2024

Wallace Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Georgia Institute of Technology, Atlanta, GA, USA.

Purpose: Expansion of the suprachoroidal space (SCS) by a hydrogel injection has been shown to reduce intraocular pressure (IOP) in rabbits as a potential treatment for ocular hypertension in glaucoma. Here, we evaluate the safety and efficacy of this approach in hypertensive and normotensive eyes in nonhuman primates.

Methods: A microneedle was used to inject a hyaluronic acid-based hydrogel or saline solution (control) into the SCS of cynomolgus monkey eyes that were either normotensive (n = 7 experimental; n = 2 control eyes) or had induced ocular hypertension (n = 6 experimental; n = 3 control eyes).

View Article and Find Full Text PDF

Background: The issue of patients returning to work is increasingly garnering attention from countries worldwide. This study aims to investigate the risk factors associated with patients returning to work after undergoing permanent enterostomies. Additionally, it seeks to establish and validate a nomogram prediction model, thereby providing a more effective reference for patients aiming to return to work.

View Article and Find Full Text PDF
Article Synopsis
  • Lisavanbulin (BAL101553) is an oral drug designed to destabilize microtubules and shows potential against glioblastoma in preclinical studies.
  • A phase 1 study was conducted to determine the maximum tolerated dose (MTD) of Lisavanbulin when given with conventional radiotherapy (RT) in patients with a specific type of glioblastoma, focusing on toxicity and effectiveness.
  • Out of 26 patients, the study found that Lisavanbulin could be safely administered at doses up to 15 mg daily, though some side effects like confusion were noted at 12 mg.
View Article and Find Full Text PDF

SUMMARYIn the United Kingdom (UK) in 2022/23, influenza virus infections returned to the levels recorded before the COVID-19 pandemic, exerting a substantial burden on an already stretched National Health Service (NHS) through increased primary and emergency care visits and subsequent hospitalizations. Population groups ≤4 years and ≥65 years of age, and those with underlying health conditions, are at the greatest risk of influenza-related hospitalization. Recent advances in influenza virus vaccine technologies may help to mitigate this burden.

View Article and Find Full Text PDF

Curriculum Research: Disseminating Neuropalliative Care Education Through an Adaptable Curriculum: A Multisite Feasibility Trial.

Neurol Educ

June 2024

From the Division of Geriatric Medicine and Palliative Care (E.H.), Department of Medicine, NYU Langone Health, New York; Department of Neurology (B.L.T., C.J.C.), University of Washington, Seattle; Department of Neurology & Neurological Sciences (H.L.K.), Stanford University School of Medicine, Palo Alto, CA; Department of Neurology (S.G., K.T.K., T.G.), New York Presbyterian-Columbia University Irving Medical Center, NY; Division of Palliative Care (K.T.B.), Departments of Neurology and Medicine, Massachusetts General Hospital, Boston; and Cambia Palliative Care Center of Excellence (C.J.C.), University of Washington, Seattle.

Introduction And Problem Statement: Neurologic disease is a leading cause of disability and death worldwide. As the global population ages, the burden of these diseases is expected to increase. Despite this increased clinical need, neurology trainees are seldom taught skills and concepts in palliative care.

View Article and Find Full Text PDF
Article Synopsis
  • - In 2018 and 2019, cowpeas in Tulare County, California were found to have serious root and stem problems that affected their growth, but only a small number of plants (less than 5%) were impacted.
  • - Scientists collected samples from these affected plants and discovered a harmful fungus called Fusarium solani, which can cause diseases in plants.
  • - They tested how this fungus could damage cowpea plants in a greenhouse and carefully measured the results to understand how it affects their growth.
View Article and Find Full Text PDF

Sm(Ⅲ), Gd(Ⅲ), and Eu(Ⅲ) complexes with 8-hydroxyquinoline derivatives as potential anticancer agents via inhibiting cell proliferation, blocking cell cycle, and inducing apoptosis in NCI-H460 cells.

Drug Dev Res

November 2024

State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, China.

Four lanthanide complexes with 8-hydroxyquinoline-2-aldehyde-2-hydrazinopyridine (H-L), 8-hydroxyquinoline-2-aldehyde-2-hydrazimidazole (H-L): [Sm(L)][Sm(L)(NO)]·CHCl·2CHOH (1), [Gd(L)][Gd(L)(NO)]·CHCl·2CHOH (2), [Sm(L)(NO)]·CHOH (3), and [Eu(L)(NO)]·CHOH (4) were synthesized and characterized. In vitro cytotoxicity evaluation showed that the ligands and four lanthanide complexes exhibited cytotoxicity to the five tested tumor cell lines. Among them, complex 1 showed the best antiproliferative activity against NCI-H460 tumor cells.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines early cardiac complications in patients with intracerebral hemorrhage (ICH), exploring how these complications relate to the stroke-heart syndrome, an under-researched area.
  • Using data from a large international stroke trial database, researchers analyzed cardiac events occurring within 30 days after ICH or acute ischemic stroke (AIS), such as heart failure and arrhythmias.
  • Results showed that while ICH patients had a lower overall rate of cardiac events compared to those with AIS, the incidence of certain complications, particularly atrial fibrillation, was significantly reduced in the ICH group.
View Article and Find Full Text PDF
Article Synopsis
  • Randomized trials in stroke often evaluate multiple outcomes, but a limitation is that all events are treated equally despite varying severity.
  • The win ratio is introduced as a new method, prioritizing clinically significant outcomes in a hierarchical order, which helps manage competing risks like death.
  • This approach has potential benefits, such as emphasizing key outcomes and combining various outcome types, and it will be applied in the upcoming ECST-2 trial, advocating for a broader use of the win ratio in future stroke research.
View Article and Find Full Text PDF

The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing.

Mol Ther Oncol

September 2024

Children's Hospital of Eastern Ontario Research Institute, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.

The mammalian reovirus Type 3 Dearing (T3D) is a naturally occurring oncolytic virus. We previously identified a T3D variant isolated from persistently infected cancer cells that has a premature stop codon mutation in the gene, generating a truncated σ1-attachment protein that lacks the globular head. We now report on the molecular characterization of this variant, named RP116, and assess its antitumor potential in human cancer cells and syngeneic mouse models.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed a large group of patients with ischemic stroke to evaluate how men and women differ in receiving recommended medications (statins, antihypertensives, anticoagulants) after discharge and their adherence to these treatments over one year.
  • * Results showed that women were prescribed fewer medications and were more likely to be non-adherent compared to men, indicating a need for improved attention to how sex influences stroke treatment and adherence.
View Article and Find Full Text PDF